Rethinking Antidepressant Medications for Children and Adolescents: Safety and Efficacy
If we followed science and safety, antidepressant drugs for anyone under the age of 24 would have never been approved.
If we followed science and safety, antidepressant drugs for anyone under the age of 24 would have never been approved.
Share Your Experience with electroconvulsive therapy (ECT) and information on litigation opportunities.
An Insider’s Revolt against Out-of-Control Psychiatric Diagnosis, DSM-5, Big Pharma, and the Medicalization of Ordinary Life
A partial screening of “A Dangerous Idea: Eugenics, Genetics and the American Dream”—an award-winning documentary exploring the legal history of the eugenics movement in the United States
Dr. Mark Horowitz, MBBS PhD is a training psychiatrist and Clinical Research Fellow in Psychiatry North East London NHS Foundation Trust (NELFT) and an Honorary… Read More »The Myth of Low-Serotonin & Antidepressants
Author and clinical psychologist Bruce Levine sits down with Open Paradigm to discuss society’s relationship to drugs, psychiatry’s increasing credibility issue, and the cultural response… Read More »Psychiatry’s credibility – Interview with Bruce Levine
BBC News. 19 October 2016. People who say their lives have been ruined by commonly prescribed antidepressants, known as SSRIs, are taking their case to… Read More »The ‘extreme’ side-effects of antidepressants
A new study published by UK researchers suggests that the long-standing and widely-accepted idea that depression is caused by a chemical imbalance and low serotonin… Read More »The Chemical Imbalance Myth of Depression
Mental American Monster “In this part of the true horror, Mental American Monster The Sprawl of American Psychiatry, nineteenth century justifications of the use of… Read More »Restraints & Solitary Confinement Part 1
Award winning doc exposing the inner workings of the pharmaceutical industry and how it created an epidemic of mental illness.
Pharmaceutical marketing goes beyond drug reps and TV ads. This activity covers how pharmaceutical companies use social psychology to affect therapeutic choices, and covers the use of key opinion leaders, medical science liaisons, medical meetings, geotargeting, geofencing, and other tactics used to market drugs to physicians.
Dr John Read is Professor of Clinical Psychology at the University of East London. He also researches the negative effects of bio-genetic causal explanations on prejudice, the experiences of recipients of anti-psychotic and anti-depressant medication, electroconvulsive therapy, and the role of the pharmaceutical industry.